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Abstract
Background The major advantage in choosing non-viral vectors such as
cationic polymers for in vitro and in vivo transfection is their higher biosafety
than viral ones. Among the cationic polymers, polyethylenimines (PEIs)
are promising molecules for gene delivery to a variety of cells. Efficient
transfection of primary endothelial cells using PEIs could be regarded
as an interesting strategy of treatment in some ischemic cardiovascular
diseases.
Methods Efficacies of a 22-kDa linear PEI (L-PEI) and its glucose-grafted
derivative (L-PEI-Glc4) were compared for gene transfer into human umbilical
vein endothelial cells (HUVEC) using the reporter gene luciferase. Cells were
incubated for 2, 4 and 24 h with PEI/DNA complexes made in 150 mM
sodium chloride (NaCl) or in 5% glucose solution. Luciferase activity was
measured 24 h after the onset of transfection. The effects of low (2%) and
high (30%) concentrations of serum on transfection efficacy were assessed
as well. We then studied the intracellular fate of the PEI/DNA complexes
labelled with the DNA intercalator YOYO-1 using flow cytometry analysis
(FACS) and confocal microscopy.
Results PEI/DNA complexes formed in NaCl led to a higher transfection
efficacy than those made in glucose. The optimal formulation, depending on
the incubation time and the presence of serum in the medium, was obtained
using DNA complexed to L-PEI-Glc4 and incubated for 4 h with the cells.
This condition led to 50% fluorescent cells after GFP transfection. A high
serum concentration diminished the L-PEI associated toxicity but decreased
L-PEI-Glc4 transfection efficiency. FACS analysis using both vectors showed
that almost 90% of the cells had internalized the DNA complexes. Confocal
microscopic observations showed a fast attachment of the complexes to the
cell surface followed by inclusion into vesicles that migrated to the perinuclear
region.
Conclusions In this work, we defined the optimal conditions for gene
delivery in HUVEC. These conditions were obtained when using derivatives
L-PEI and L-PEI-Glc4 complexed with DNA in 150 mM NaCl and added
to cells for 2 and 4 h, respectively. Cellular trafficking of the complexes
suggested that cell entry was not a limiting factor for gene delivery using
PEI. This study underlined the interest in PEIs as efficient vectors for gene
transfer into human endothelial cells. Copyright  2004 John Wiley & Sons,
Ltd.
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Introduction
The vascular endothelium plays a key role in maintaining
blood-vessel-wall homeostasis. Endothelial disturbance
has indeed been shown to be involved in the occurrence
and/or progression of an increasing number of vascular
disorders. Although significant progress has been made
in the treatment of these pathologies, some of them
remain refractory to conventional treatment and may
benefit from new therapeutic approaches such as gene
transfer targeted to endothelial cells. However, transfec-
tion of the endothelium in vivo or of primary endothelial
cells in vitro remains poorly studied and the few studies
published underline their resistance as a target for gene
transfer [1–4]. On the other hand, gene therapy strategies
require the use of efficient and harmless vectors capable of
transporting and delivering the gene into the target cells
since naked DNA has been shown to be poorly efficient in
most cases [5]. Viral vectors such as retroviruses or aden-
oviruses exhibit high transfection efficiency but their clin-
ical use is limited by low DNA packaging capacities, diffi-
culties in ensuring safe and low cost production and stor-
age, stimulation of immune response, risk of insertional
mutagenesis and of self replication [6,7]. Thus, many
efforts have been undertaken to develop non-viral vectors
such as peptides, proteins, liposomes and polymers [8].
Particular interest has been given to the second
generation of these non-viral vectors. Among them,
polyethylenimine (PEI) has been successfully used for
transfection of various cell types in vitro as well as in vivo
[9–11]. These cationic polymers capable of buffering
acidic endosomes lead to a higher gene expression level
than conventional cationic liposomes when administered
by systemic [12] or the intratracheal route [13]. Other
derivatives such as linear PEI (L-PEI) [14] or glycosylated
PEI have been developed from the parent compound.
These vectors offer several advantages such as a better
efficacy and a lower toxicity [15–17]. Indeed glycosylated
PEI was shown to increase both solubility of the complexes
and gene transfer efficiency into fragile cells [18,19].
The aim of this study was to optimize the conditions
for gene delivery to primary human endothelial cells
isolated from umbilical vein (HUVEC) using L-PEI and a
tetraglucose-grafted L-PEI (L-PEI-Glc4). Several features
of the transfection protocol were examined including the
nature of the PEI/DNA complexation solution and the
effects of both incubation time of the complexes with
the cells and serum concentration. We also studied the
cellular uptake of the complexes using flow cytometry and
confocal microscopy to better understand the mechanism
of interaction between these vectors and the target cell.
Materials and Methods
Primary endothelial cells
Endothelial cells from human umbilical veins (HUVEC)
were isolated as described previously [20]. Briefly, the
veins were rinsed with phosphate-buffered saline (PBS)
and treated with 0.1% (w/v) collagenase (Invitrogen,
Cergy-Pontoise, France) for 15 min at 37 ◦C. The cell
culture medium was composed of a mixture (v/v) of M199
25 mM HEPES and RPMI 1640 (Invitrogen) supplemented
with 30% of pooled heat-inactivated human serum
(Etablissement Franc¸ais du Sang, Strasbourg, France) and
0.1% gentamicin [21]. HUVEC were cultured in 75-cm2
flasks coated with 10 µg/ml of fibronectine (Sigma, St
Quentin Fallavier, France), at 37 ◦C in a humid 5% CO2
atmosphere and used between passage two and passage
four.
Plasmid vector
The transfections were performed using 2 µg per well
of plasmids encoding either the firefly luciferase gene
(pCMV-Luc) or the enhanced green fluorescent protein
gene (pCMV-EGFP) (Clontech). Each plasmid contains the
cytomegalovirus-immediate early promoter. The plasmids
were amplified at sufficient amount by standard molecular
biology techniques using the Qiagen Maxi-Prep kit
(Qiagen S.A., Courtaboeuf, France) for the harvest and
the purification of the plasmid.
Cationic vectors
Two formulations of polyethylenimine (PEI) were used in
our study, a 22-kDa linear PEI (L-PEI) and a tetraglucose-
conjugated PEI (L-PEI-Glc4). Both PEIs were purchased
from Polyplus-Transfection SAS (Illkirch, France). L-
PEI-Glc4 was obtained by grafting linear chains of
four glucosyl residues on L-PEI amino groups. Briefly,
linear tetraglucose (Glc4) and sodium cyanoborohydride
(25 µmol) were added to PEI in 0.9 ml of borate buffer
(0.2 M, pH 8.2) and left for 96 h at room temperature
with stirring. The extent of grafting, expressed as the
percentage of glucosyl residues per amino group of PEI,
is 5% [19]. The PEI was used as a 100 mM aqueous
stock solution and stored at – 20 ◦C. The PEI/DNA ratio
(5 : 1) was determined in previous studies [14]. A volume
of 0.3 µl of the PEI stock solution was added to 2 µg
of DNA. For each well, L-PEI, L-PEI-Glc4, and DNA were
diluted separately in 50 µl of 150 mM NaCl or 5% glucose.
After 10 min, the PEI/DNA complexes were generated by
mixing the L-PEI or L-PEI-Glc4 solutions with the DNA.
This transfection solution was allowed to stand for 10 min
at room temperature before being added to the cells.
The PolyFect and SuperFect reagents (Qiagen) were
used following the recommendations of the manufacturer.
Briefly, for each well, 12 and 8 µl of respectively
stock solutions of PolyFect (2 mg/ml) and SuperFect
(3 mg/ml) were added to 2 µg DNA diluted in 60 µl
of DMEM-Glutamax. This solution was incubated at room
temperature for 15 min to allow complex formation before
being added to the cells.
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The liposome formulations DOSPA/DOPE, at 1 : 1
(w/w), and DOTMA/DOPE were purchased from Invit-
rogen as respectively lipofectAMINE and lipofectIN and
used following the recommendations of the manufacturer.
Briefly, for each well, 4 µl of stock solution (2 mg/ml)
were diluted in 50 µl of DMEM-Glutamax (Invitrogen)
and allowed to stand at room temperature for 30 min.
This solution was mixed with 2 µg of DNA in 50 µl
DMEM. Liposome/DNA complexes were allowed to form
for 10 min before being added to the cells.
Cell transfection
HUVEC were seeded at an initial cell density of
3.5 × 104 cells/well in fibronectin-coated 24-well plates
and allowed to grow overnight before transfections. At the
time of transfection, cells were at about 70% confluency.
HUVEC were incubated for 2, 4 and 24 h with the
transfection solution in the presence of a 2 or 30% serum
content. For all conditions, gene expression was measured
24 h after the onset of transfection. PEI/DNA complexes
(100 µl/well) were added to cell wells containing 500 µl
of culture media supplemented with either 2 or 30%
of human serum. For the 2 and 4 h incubation times,
the transfection medium was discarded after respectively
2 and 4 h and replaced with fresh complete medium.
For the 24 h condition, the transfection solution was
incubated with the cells until the transgene measurement
was performed.
PolyFect and SuperFect complexed to DNA were
added to cell wells that contained 500 µl of DMEM-
Glutamax (Invitrogen) without antibiotics and supple-
mented with 2% of human serum. After 2 h of transfec-
tion, the medium was removed and replaced with HUVEC
growth medium. Gene expression was measured 24 h
after the onset of transfection.
Liposome-mediated transfections followed the manu-
facturer’s recommendations. Liposome/DNA complexes
were added to cell wells that contained 500 µl of
DMEM-Glutamax (Invitrogen) without antibiotics and
supplemented with 2% of human serum. After 3 h of
transfection, the medium was removed and replaced with
HUVEC growth medium. Gene expression was measured
24 h after the onset of transfection. Each condition was
prepared in triplicate and the experiments were carried
at least three times.
Luciferase assay
Twenty-four hours after the addition of the transfection
solution, the cells were washed once with PBS, lysed
by the addition of 150 µl of cell culture lysis reagent
(Promega, Charbonnieres, France) and luciferase gene
expression was quantified using a commercial kit
(Promega) and a luminometer (Minilum, Fischer Bioblock
Scientific, Illkirch, France). Results are expressed as
relative light units (RLU) integrated over 10 s per well.
EGFP expression
HUVEC were incubated with L-PEI/DNA for 2 h and
with L-PEI-Glc4/DNA for 4 h. Twenty-four hours after
the addition of the transfection solution containing 2%
serum, the cells were evaluated for expression of the
enhanced green fluorescent protein (EGFP) by flow
cytometry (FACScan, Becton Dickinson, Le Pont-De-
Claix, France), using an argon laser at a wavelength of
488 nm. Briefly, untransfected cells used for background
calibration and transfected cells were harvested by
trypsinization, centrifuged and resuspended in 1 ml of
PBS for direct FACS analysis. Flow cytometry was carried
out by counting the number of GFP-expressing cells in the
population of 10 000 viable cells. Cytometry analyses were
performed using CellQuest (Becton Dickinson) software.
Cellular toxicity
In vitro toxicity was assessed by quantification of the
cellular content in proteins. The cells were transfected
in the presence of a 2 or 30% serum content with
PEI/DNA complexes in 150 mM NaCl. Twenty-four hours
after the addition of the transfection solution, the cells
were washed once in PBS and lysed by the addition
of 150 µl of cell culture lysis reagent (Promega). The
cellular proteins were measured using the bicinchoninic
acid assay (Interchim, Montluc¸on, France) following an
incubation time of 40 min at 60 ◦C. The absorbance was
read at 570 nm using a microplate reader (Labsystems
SA, Cergy-Pontoise, France). The toxicity of the different
conditions was expressed as relative toxicity (%):
Relative toxicity(%)
=
[(protein amount of control cells
−protein amount of transfected cells)
protein amount of control]
× 100.
Flow cytometry
The incorporation of DNA into cells was analyzed by flow
cytometry. Plasmid DNA (2 µg) was labelled with the
fluorophore YOYO-1 (Interchim) at a final concentration
of 4 × 10−6 M followed by 10 min incubation in 50 µl of
5% glucose. The PEI/DNA complexes were prepared as
described above and added to cells for 2 and 4 h. The
cells were extensively washed with PBS and harvested
by trypsinization. Cells were recovered in 1 ml of PBS
and the individual fluorescence of 10 000 cells was
quantified by flow cytometry analysis (FACScan, Becton
Dickinson, Le Pont-De-Claix, France), using an argon
laser at a wavelength of 488 nm. Data were analyzed
using the CellQuest (Becton Dickinson) software and were
expressed as the percentage of positive cells containing
the labelled DNA.
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Confocal microscopy
The intracellular path of PEI/DNA complexes was studied
by confocal microscopy. HUVEC were grown overnight
on fibronectin pre-treated chamber slides at a density
of 18 000 cells per chamber. Cells were transfected with
L-PEI-Glc4/YOYO-1-labelled DNA and observed with a
confocal microscope (BioRad MRC1024ES, Elexience,
Verrie`res-le-buisson, France) at 40 min, 2 h, 4 h and 24 h
after the addition of the PEI/DNA complexes. Excitation
of the cells containing the YOYO-1-labelled DNA was
achieved at 488 nm and the resulting fluorescence
emission was observed using a 515–540 nm band pass
filter. The cells ranged in thickness between 2 and 4 µm
with confocal sections taken every 0.4 µm.
Statistics
Results are expressed as the mean of triplicate exper-
iments and the error bars represent the corresponding
standard deviation. The mean of each group was com-
pared by an unpaired two-tailed Student’s t-test or one-
way analysis of variance (ANOVA) followed by a multiple
comparison procedure.
Results
Optimization of transfection conditions
We first studied the effect on gene expression of varying
the transfection solution. PEI and DNA were mixed
either in 100 µl of 150 mM NaCl or 5% glucose. The
transfection solution was added to 500 µl of culture
medium containing 2% serum for 2, 4 and 24 h. In all
conditions, gene expression was measured 24 h after the
onset of transfection. The overall efficacy of transfection
was dramatically higher when complexes were prepared
in 150 mM NaCl than in 5% glucose (Figure 1). When
DNA/L-PEI complexes were formed in 150 mM NaCl,
gene expression reached a maximum for the 2 h
incubation time, then decreased for longer incubation
times. Transfection efficacy in HUVEC incubated 4 h
with the formulation L-PEI-Glc4 in 150 mM NaCl was
significantly higher than the optimal formulation of L-PEI
in 150 mM NaCl (p < 0.05, Figure 1).
Influence of serum on gene expression
Transfection was performed using high (30%) and low
(2%) concentrations of serum for the indicated incubation
times (2, 4 and 24 h). When using the L-PEI at high serum
concentration, we did not observe a fall in gene expression
with increasing incubation time (Figure 2A). With L-PEI-
Glc4, there was a significant decrease in gene expression
at high serum concentration when HUVEC were incubated
2 and 4 h with the transfection solution (Figure 2B).
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Figure 1. Effects of L-PEI (open columns) and L-PEI-Glc4 (black
columns) on gene expression in HUVEC. PEI derivatives were
complexed to DNA in 150 mM NaCl or in 5% glucose. HUVEC
were incubated for 2, 4 and 24 h. Luciferase activity was
measured 24 h after transfection (∗p < 0.05)
Toxicity
The toxicity of the PEI derivatives was investigated in
HUVEC incubated for 2, 4 and 24 h in the presence of
2 or 30% of serum. The L-PEI/DNA complexes induced
a significantly higher toxicity than the L-PEI-Glc4/DNA
complexes for the 2 and 4 h incubation (p < 0.01 and
p < 0.05, respectively; Figure 3). There was no difference
between the two polymers when the cells were transfected
over a 24 h period in the presence of 2% of serum. The
addition of serum in the transfection medium to a final
concentration of 30% induced a 50% reduction in L-PEI
toxicity and completely abrogated the cell toxicity induced
by L-PEI-Glc4 when added to the cells for 4 h.
Percentage of transfected cells
In order to measure the percentage of transfected cells
when using the optimal formulations for L-PEI and L-
PEI-Glc4, we used the EGFP as a marker gene and
measured the gene expression by FACS analysis. The
optimized L-PEI-Glc4 (i.e. L-PEI-Glc4 in 150 mM NaCl, 4 h
incubation time) corresponded to 50% cells positive for
EGFP (Figure 4). This result showed a higher fluorescence
in EGFP-positive cells than the transfection with the
optimal L-PEI formulation (i.e. L-PEI in 150 mM NaCl,
2 h incubation time; Figure 4).
L-PEI-Glc4 and L-PEI were compared with the cationic
lipids (lipofectAMINE and lipofectIN) and with other
cationic polymers such as polyamidoamine dendrimers
(PolyFect and SuperFect). The cationic lipids and the
dendrimers were used according to the manufacturers’
recommendations. Optimized formulations achieved a
Copyright  2004 John Wiley & Sons, Ltd. J Gene Med 2004; 6: 176–184.
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Figure 2. Effect of low (2%) (open columns) versus high (30%) (hatched columns) concentrations of serum on transfection
efficiency of (A) L-PEI and (B) L-PEI-Glc4. HUVEC were incubated for 2, 4 and 24 h in the presence of 150 mM NaCl. Luciferase
activity was measured 24 h after transfection (∗∗p < 0.01; ∗∗∗p < 0.001)
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Figure 3. Cytotoxicity of L-PEI (open columns) and L-PEI-Glc4 (black columns) in HUVEC. The cells were incubated in the presence
of 2 or 30% of serum for 2, 4 and 24 h with PEI/DNA complexes in 150 mM NaCl. Relative toxicity was evaluated 24 h after
transfection (∗p < 0.05, ∗∗p < 0.01)
significantly higher gene expression than both dendrimers
and cationic lipids (Figure 5).
Endothelial cell uptake of L-PEI/DNA
complexes
In the second part of this work, we studied the abil-
ity of HUVEC to bind and take up DNA/complexes into
their cytoplasm by FACS analysis of the fluorescence of
YOYO-1-labelled complexes. The percentage of cells that
internalized DNA and the amount of DNA (measured in
the FL1 channel of the cytometer used) into the cells
were measured. The entry of complexes into HUVEC
varied with the incubation time and with the type of
PEI used. With both PEI derivatives, the amount of DNA
in the cells and the percentage of cells internalizing DNA
increased with incubation time (Figures 6A and 6B). After
2 h incubation time, 73–82% of cells have incorporated
the complexes respectively with L-PEI-Glc4 and with L-PEI
(Figure 6A). In this condition the cells transfected with
either L-PEI or L-PEI-Glc4 incorporated similar amounts
of DNA (Figure 6A). After 4 h of transfection, additional
cells took up DNA with both vectors. Some 94–95% of
cells have incorporated DNA with respectively L-PEI and
L-PEI-Glc4 (Figure 6B). However, a significant difference
in the amount of internalized DNA appeared when the
transfection duration was augmented to 4 h, since the
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Figure 4. FACS analysis quantifying EGFP expression in HUVEC.
Panels display results of FL1-H fluorescence measurement of
10000 cells transfected with the optimized L-PEI (upper) or
L-PEI-Glc4 (lower) formulations complexed with pCMV-EGFP in
150 mM NaCl
level of DNA uptake obtained with L-PEI-Glc4 was higher
than with L-PEI (Figure 6B).
Intracellular trafficking of the
complexes
Plasmid DNA was fluorescently labelled with YOYO-1
and complexed with PEIs then added to HUVEC. The
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Figure 5. Comparison of transfection efficacy of PEI and com-
mercially available vectors such as PolyFect, SuperFect, lipo-
fectIN and lipofectAMINE in HUVEC. Cells were transfected using
optimal conditions established for each vectors (∗∗∗p < 0.001,
L-PEI-Glc4 vs. the other agents tested)
cells were observed under confocal microscopy at various
time points allowing the visualization of the cellular
entry and trafficking of the complexes. After 40 min,
fluorescent clumps were already visible on the cell surface
(Figure 7A). Two hours after transfection, patches of
fluorescence were seen around the plasma membrane
and some of them appeared in the cytoplasm below
the plasma membrane (Figure 7B). Large and numerous
fluorescent dots that may correspond to endocytosic
vesicles were seen in the entire cytoplasm. After 4 h,
fluorescence increased around the nuclei and stayed in
perinuclear areas (Figure 7C). After 24 h, large patches of
fluorescence appeared in the nucleus vicinity (Figure 7D).
Discussion
Endothelial cells are attractive targets for vascular gene
therapy. However, their ability to internalize and express
exogenous DNA has so far been poorly addressed. In
this work, we evaluated the transfection efficiency of
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Figure 6. Comparison of DNA entry into HUVEC vectorized by L-PEI or L-PEI-Glc4 after (A) 2 h and (B) 4 h incubation time points.
Cells were harvested and analyzed by flow cytometry as described in ‘Materials and Methods’
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Figure 7. Cell interactions of L-PEI-Glc4/DNA complexes.
Confocal microscopy (A) 40 min, (B) 2 h, (C) 4 h, and (D) 24 h
after transfection. Light transmission left panel, fluorescence
right panel. Labelled complexes are indicated by arrows.
Arrowheads indicate the nuclei of the cell. Scale bars represent
50 µm
two PEI derivatives towards primary human endothelial
cells. The PEI offers several desirable features in terms
of synthetic vector-mediated gene transfer. Indeed, every
third atom of each PEI molecule is a nitrogen atom that
can be protonated, thus conferring to the molecule a high
DNA-condensing and a high buffering capacity [10]. The
DNA-condensing property of the PEI is mediated by strong
ionic interactions between positively charged primary
amines and the negatively charged phosphate groups
of the DNA. The ratio of PEI nitrogens to DNA phosphates
affects the mean size and the polydispersity of the particles
[14]. Thus, the choice of relative concentrations of PEI
and DNA are critical factors that modify dramatically the
transfection efficacy of the complexes. High expression
levels were found in most cell lines transfected with
complexes bearing a net positive charge which facilitates
their interaction with negatively charged cell surface
proteoglycans [22–24]. In our study, we used L-PEI at a
5 : 1 PEI amine/DNA phosphate ratio which corresponds
to positively charged complexes and was previously shown
to allow the efficient transfection of various cell types
[14]. In our experiments, the gene transfer efficacy is
highly dependent on the ionic strength of the PEI/DNA
mixing solution. Transfection complexes prepared in
150 mM NaCl led to a 4- to 25-fold higher luciferase
gene expression than those prepared in 5% glucose. When
using the EGFP expression analysis, the complexes formed
in 150 mM NaCl achieved transfection levels of up to
50% transfected cells. The ionic strength of the PEI/DNA
mixing solution influences the size and the morphology
of the particles [16,25,26]. Under physiological salt
concentration, PEI/DNA complexes rapidly aggregated
into large particles (1 µm), while complexes made in
5% glucose remained much smaller (<100 nm) [16].
In accordance with recent works by other groups, we
found that the best transfection conditions are obtained
with large particles made in sodium chloride [26,27].
The higher transfection efficacy exhibited by the large
aggregated particles results from the conjunction of
several features [26]: (i) they sediment onto the cell
surface more rapidly than the small complexes, (ii) since
they contain a large proportion of free cationic polymers
in addition to those complexed with DNA, they destabilize
the membrane favoring their entry into cells, and
(iii) their endosomolytic activity is far higher than that
of the small particles. The PEI acts as a proton sponge;
protonation of PEI within acidic compartments such as
late endosomes presumably triggers osmotic swelling and
destabilization of the vesicles [14,28].
In our study, L-PEI induced a significantly higher
cell toxicity than L-PEI-Glc4. Toxicity increased with
incubation time and was dependent on the type of vector
used to transfect cells. The extensive grafting with glycosyl
residues led to beneficial electrostatic shielding of the
surface of particles which are less positively charged with
increased hydrophilicity and biodisponibility compared
with L-PEI/DNA complexes [25]. Thus, the comparison of
cell viability after transfection of human carcinoma cells
with PEI derivatives showed that glycosylated PEIs were
less cytotoxic than unsubstituted PEIs [18]. Consequently,
this may explain why, in our work, L-PEI caused a greater
toxicity of HUVEC than L-PEI-Glc4. On the other hand,
DNA complexes formed with L-PEI-Glc4 or L-PEI can
form aggregates at physiological salt concentration. This
physical characteristic of PEI/DNA particles was shared
by the branched form of PEI, shown to favor particle
aggregation in physiological conditions [29]. Therefore,
particle aggregation could increase transfection efficiency
but also cell toxicity by a possible process of membrane
destabilization [30,31].
HUVEC were transfected in low serum in order
to reduce the interaction between negatively charged
proteins present in serum and cationic particles that
could decrease the transfection efficacy of the complexes
[26]. In this work, the addition of serum to the medium
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during transfection reduced the cytotoxicity of L-PEI/DNA
complexes prepared in 150 mM NaCl. It was previously
shown that the presence of serum in the culture medium
prevents the salt-induced aggregation and subsequent cell
toxicity of PEIs [26]. This toxicity could result from entry
of PEI/DNA complexes into the cytoplasm or into the
nuclei of the cells [32]. Moreover, a large amount of free
polycations [33] may play a toxic role. In contrast, the
highest transfection efficiency achieved by L-PEI-Glc4 is
decreased by the addition of the serum. This result is
in agreement with the hypothesis that cationic particles
interact with serum proteins, hence reducing the amount
of complexes able to interact with the cell membrane [26].
In our work, PEI derivatives were significantly more effi-
cient than the other commercially available vectors such
as cationic lipids lipofectAMINE and lipofectIN or cationic
polyamidoamine dendrimers PolyFect and SuperFect,
hence demonstrating that PEIs are efficient vectors for
endothelial gene transfer. These results were in agree-
ment with recent data obtained with other cell lines
[18,19,34,35]. PEI-mediated delivery of DNA to the cyto-
plasm and the nucleus could increase the transfection
efficacy of both vectors [36–39]. Indeed, the injection
of cDNA complexed with cationic lipids or PEI into the
cytoplasm or into the nuclei of cells showed that DNA
complexed with PEI could produce gene expression with-
out disruption of the transcription process while cationic
lipids showed no expression of the transgene [38].
We also investigated internalization of PEI/DNA
complexes. We showed that the uptake of DNA increased
with duration of the transfection process and was
correlated with gene expression. Two hours after
incubation with the complexes, almost all cells have
internalized the DNA, although the analysis of the
percentage of transfected cells after 24 h using EGFP
showed that 50% of cells expressed the green fluorescent
protein. Apparently, the limiting step in the expression
of the transgene would not be localized at the plasma
membrane level since the percentage of cells that
incorporated the DNA reached 95% in the best conditions.
The endocytic trafficking as well as other intracellular
barriers, including nuclear transport of the gene, could be
important limits for gene expression in vitro.
When the intracellular routes of PEI/DNA complexes
were observed in HUVEC by confocal microscopy, the
kinetics of cellular attachment of the complexes and of
their migration into vesicular compartments was similar
to that observed in an endothelial cell line (EAhy 926)
by other authors [33]. The attachment of PEI/DNA
complexes was observed 40 min after incubation, 2 h
later taken up in endosomes and then localized in the
perinuclear region after 4 h incubation. Nevertheless, the
trafficking and localization of the complexes to the nucleus
remain questionable. Godbey et al. found PEI and DNA
inside nuclei of EAhy 926 cells after 3–4 h incubation with
PEI. For other groups, using confocal microscopy, there
was no evidence of nucleus localization of the complexes
[40]. Besides this conflicting observation the transfection
efficacy does not seem to be related to this particular step.
In conclusion, our study has established that HUVEC
can be efficiently transfected when using polyethyleimines
to transfer DNA into cells as compared with other non-
viral agents such as cationic lipids.
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